Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verubulin + Carboplatin in Recurrent Glioblastoma
NCT00635557Phase 2Unknown
- Sponsor
- Myrexis, Inc.
- Start
- Mar 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verubulin in glioblastoma multiforme (GBM), sponsored by Myrexis, Inc.. Status: unknown.
02
Drugs
verubulin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00635557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635557.